![Harold Fleming](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Harold Edward Fleming is currently Independent Director at CRISPR Therapeutics AG since 2021, Director at Komodo Health, Inc. since 2021, Director-Visitors Board at Vanderbilt School of Medicine Basic Sciences, Independent Director at Upstream Bio, Inc. since 2023, Independent Non-Executive Director at Sionna Therapeutics, Inc. since 2024, Director at Sudo Biosciences, Inc., Director at Egnite, Inc., and Executive Vice President at Enavate Sciences since 2022.
Formerly, Senior Partner at Mckinsey & Co., Inc. (California) from 1997 to 2022.
Education includes undergraduate degree from Harvard University and doctorate from Vanderbilt University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
UPSTREAM BIO, INC. -.--% | 09/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 05/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 17/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CRISPR THERAPEUTICS AG | Director/Miembro de la Junta | 10/06/2021 |
| UPSTREAM BIO, INC. | Director/Miembro de la Junta | 08/06/2023 |
| SIONNA THERAPEUTICS, INC. | Director/Miembro de la Junta | 01/03/2024 |
Komodo Health, Inc.
 Komodo Health, Inc. Packaged SoftwareTechnology Services Provides AI-powered healthcare intelligence platform that leverages real-world patient data and AI-powered analytics to deliver insights that improve patient outcomes and healthcare system efficiency | Director/Miembro de la Junta | 30/11/2021 |
Vanderbilt School of Medicine Basic Sciences
 Vanderbilt School of Medicine Basic Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Director/Miembro de la Junta | - |
Enavate Sciences
 Enavate Sciences Financial ConglomeratesFinance Invests and supports therapeutic & enabling technology companies | Corporate Officer/Principal | 01/11/2022 |
Sudo Biosciences, Inc.
 Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Director/Miembro de la Junta | - |
Egnite, Inc.
 Egnite, Inc. Packaged SoftwareTechnology Services Provides artificial intelligence and big data analytics solutions that help to close gaps that can cause under treatment in structural heart disease | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Mckinsey & Co., Inc. (California)
 Mckinsey & Co., Inc. (California) Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Corporate Officer/Principal | 01/08/2022 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanderbilt University
 Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Komodo Health, Inc.
Komodo Health, Inc. Packaged SoftwareTechnology Services Provides AI-powered healthcare intelligence platform that leverages real-world patient data and AI-powered analytics to deliver insights that improve patient outcomes and healthcare system efficiency | Technology Services |
Mckinsey & Co., Inc. (California)
Mckinsey & Co., Inc. (California) Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
Sudo Biosciences, Inc.
Sudo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that designs and develops medicines that target the tyrosine kinase | Health Technology |
Egnite, Inc.
Egnite, Inc. Packaged SoftwareTechnology Services Provides artificial intelligence and big data analytics solutions that help to close gaps that can cause under treatment in structural heart disease | Technology Services |
Vanderbilt School of Medicine Basic Sciences
Vanderbilt School of Medicine Basic Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enavate Sciences
Enavate Sciences Financial ConglomeratesFinance Invests and supports therapeutic & enabling technology companies | Finance |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
